Louisville Coronavirus Surveillance Program

Julio Ramirez
{"title":"Louisville Coronavirus Surveillance Program","authors":"Julio Ramirez","doi":"10.18297/jri/vol4/iss1/3","DOIUrl":null,"url":null,"abstract":"ULJRI | https://doi.org/10.18297/jri/vol4/iss1/3 1 Abstract An important feature of COVID-19, the disease produced by the new coronavirus SARS-CoV-2, is the high number of health care workers (HCWs) that acquire the disease. In an initial report of 138 patients hospitalized with COVID-19 pneumonia in China, 40 patients (29%) were HCWs. One reason why HCWs are at higher risk of acquiring COVID-19 is because some patients with COVID-19 are admitted to the hospital without the classical presentation, and are therefore not tested for the disease early during hospitalization. Presently in the US, it is recommended to test for COVID-19 when physicians suspect the disease. This subjective approach may allow hospital transmission of COVID-19 from patients without the classical clinical presentation. The primary objective of this study is to establish a surveillance system for early identification of patients hospitalized with COVID-19 to allow for early implementation of infection control interventions in an attempt to prevent transmission of COVID-19 to HCWs and other hospitalized patients. We are proposing to test all patients who present to the emergency departments and/ or are hospitalized with signs and symptoms of respiratory infection or gastrointestinal infection for SARS-CoV-2, regardless of clinical suspicion of COVID-19. Biological samples obtained from all patients having symptoms of respiratory or gastrointestinal infection will be tested using real-time polymerase chain reaction (RT-PCR) for detection of SARS-CoV-2. Using a robotic instrument, the CMP laboratory will be able to test more than 500 samples a day. Data will be reported in real-time to participating hospitals for rapid implementation of infection control measures.","PeriodicalId":91979,"journal":{"name":"The University of Louisville journal of respiratory infections","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The University of Louisville journal of respiratory infections","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18297/jri/vol4/iss1/3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

ULJRI | https://doi.org/10.18297/jri/vol4/iss1/3 1 Abstract An important feature of COVID-19, the disease produced by the new coronavirus SARS-CoV-2, is the high number of health care workers (HCWs) that acquire the disease. In an initial report of 138 patients hospitalized with COVID-19 pneumonia in China, 40 patients (29%) were HCWs. One reason why HCWs are at higher risk of acquiring COVID-19 is because some patients with COVID-19 are admitted to the hospital without the classical presentation, and are therefore not tested for the disease early during hospitalization. Presently in the US, it is recommended to test for COVID-19 when physicians suspect the disease. This subjective approach may allow hospital transmission of COVID-19 from patients without the classical clinical presentation. The primary objective of this study is to establish a surveillance system for early identification of patients hospitalized with COVID-19 to allow for early implementation of infection control interventions in an attempt to prevent transmission of COVID-19 to HCWs and other hospitalized patients. We are proposing to test all patients who present to the emergency departments and/ or are hospitalized with signs and symptoms of respiratory infection or gastrointestinal infection for SARS-CoV-2, regardless of clinical suspicion of COVID-19. Biological samples obtained from all patients having symptoms of respiratory or gastrointestinal infection will be tested using real-time polymerase chain reaction (RT-PCR) for detection of SARS-CoV-2. Using a robotic instrument, the CMP laboratory will be able to test more than 500 samples a day. Data will be reported in real-time to participating hospitals for rapid implementation of infection control measures.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
路易斯维尔冠状病毒监测项目
摘要由新型冠状病毒SARS-CoV-2引发的新型冠状病毒COVID-19的一个重要特征是大量医护人员感染该疾病。在中国因COVID-19肺炎住院的138例患者的初步报告中,40例患者(29%)是医护人员。医护人员感染COVID-19的风险较高的一个原因是,一些COVID-19患者入院时没有典型的症状,因此在住院期间没有及早进行疾病检测。目前在美国,当医生怀疑患有COVID-19时,建议进行检测。这种主观的方法可能使COVID-19从没有经典临床表现的患者传播到医院。本研究的主要目的是建立监测系统,早期识别住院患者COVID-19,以便及早实施感染控制干预措施,防止COVID-19传播给医护人员和其他住院患者。我们建议对所有出现呼吸道感染或胃肠道感染症状和体征的急诊科和/或住院患者进行SARS-CoV-2检测,无论临床是否怀疑COVID-19。将使用实时聚合酶链反应(RT-PCR)对所有有呼吸道或胃肠道感染症状的患者采集的生物样本进行检测,以检测SARS-CoV-2。使用机器人仪器,CMP实验室将能够每天测试500多个样本。数据将实时报告给参与的医院,以便迅速实施感染控制措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
7 weeks
期刊最新文献
COVID-19 Hospital Mortality Among Patients with Invasive Mechanical Ventilation: A Comparison Between Public and Private Healthcare Services in San Luis Potosí 2020–2022 COVID-19 Hospital Mortality Among Patients with Invasive Mechanical Ventilation: A Comparison Between Public and Private Healthcare Services in San Luis Potosí 2020–2022 Neurotropic Manifestations as a Potential Risk Factor for Schizophrenia Following in utero Exposure to SARS-CoV-2 On the Respiratory Syncytial Virus Vaccine The Impact Of The COVID-19 Pandemic On Respiratory Syncytial Virus
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1